Acetaminophen And Codeine Phosphate recalls
Acetaminophen And Codeine Phosphate products have been recalled 4 times, most recently on 22 Apr 2020. The recalling company is usually Aurobindo Pharma USA. The most common reason is manufacturing (cgmp) deviations.
Total recalls4since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 22 Apr 2020
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 4 100%Class III 0 0%
Why acetaminophen and codeine phosphate is recalled
Companies
Product types
By year
All acetaminophen and codeine phosphate recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Acetaminophen and Codeine Phosphate Tablets, USP, 300 mg/30 mg recalledAcetaminophen And Codeine Phosphate | Aurobindo Pharma USA | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Acetaminophen and Codeine Phosphate Tablets, USP, 300 mg/15 mg recalledAcetaminophen And Codeine Phosphate | Aurobindo Pharma USA | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Acetaminophen and Codeine Phosphate Tablets, USP, 300 mg/60 mg recalledAcetaminophen And Codeine Phosphate | Aurobindo Pharma USA | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Acetaminophen 300 mg with Codeine Phosphate, USP M-Pak containers recalledAcetaminophen And Codeine Phosphate | Prescript Pharmaceuticals | Other | CA |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.